C Diff Vaccine Shows Lot Consistency, Induces Toxin A and B Antibody Responses
Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.
Source: hcplive.com